Global Central Nervous System Drugs Sales Market Report 2016

October 2016 | 137 pages | ID: GD14B6F7890EN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:

• USA
• China
• Europe
• Japan
• India
• Southeast Asia

The Major players reported in the market include:

• Johnson & Johnson
• Pfizer
• Novartis
• Roche
• Sanofi-Aventis
• Merck
• GSK
• Bayer Schering
• Bristol-Myers Squibb
• AbbVie
• Eli Lilly
• AstraZeneca
• Takeda
• Actavis
• Astellas Pharma US
• Teva
• Biogen
• Shire

Product Segment Analysis:

• Type I
• Type II
• Type III

Application Segment Analysis:

• Application I
• Application II
• Application III

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 CENTRAL NERVOUS SYSTEM DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Central Nervous System Drugs
1.2 Classification of Central Nervous System Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Central Nervous System Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Central Nervous System Drugs Market States Status and Prospect (2011-2021) by Regions
  1.4.1 USA
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
  1.4.5 India
  1.4.6 Southeast Asia
1.5 Global Market Size of Central Nervous System Drugs (2011-2021)
  1.5.1 Global Central Nervous System Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Global Central Nervous System Drugs Revenue and Growth Rate (2011-2021)

2 GLOBAL ECONOMIC IMPACT ON CENTRAL NERVOUS SYSTEM DRUGS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
2.3 Effects to Central Nervous System Drugs Industry

3 CENTRAL NERVOUS SYSTEM DRUGS MAUFACTURING COST ANALYSIS

3.1 Central Nervous System Drugs Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Central Nervous System Drugs

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Central Nervous System Drugs Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Central Nervous System Drugs Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL CENTRAL NERVOUS SYSTEM DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Central Nervous System Drugs Market Competition by Manufacturers
  5.1.1 Global Central Nervous System Drugs Sales and Market Share of Key Manufacturers (2011-2016)
  5.1.2 Global Central Nervous System Drugs Revenue and Share by Manufacturers (2011-2016)
5.2 Global Central Nervous System Drugs (Volume and Value) by Type
  5.5.1 Global Central Nervous System Drugs Sales and Market Share by Type (2011-2016)
  5.5.2 Global Central Nervous System Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Central Nervous System Drugs (Volume and Value) by Regions
  5.3.1 Global Central Nervous System Drugs Sales and Market Share by Regions (2011-2016)
  5.3.2 Global Central Nervous System Drugs Revenue and Market Share by Regions (2011-2016)
5.4 Global Central Nervous System Drugs (Volume) by Application

6 USA CENTRAL NERVOUS SYSTEM DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 USA Central Nervous System Drugs Sales and Value (2011-2016)
  6.1.1 USA Central Nervous System Drugs Sales and Growth Rate (2011-2016)
  6.1.2 USA Central Nervous System Drugs Revenue and Growth Rate (2011-2016)
  6.1.3 USA Central Nervous System Drugs Sales Price Trend (2011-2016)
6.2 USA Central Nervous System Drugs Sales and Market Share by Manufacturers
6.3 USA Central Nervous System Drugs Sales and Market Share by Type
6.4 USA Central Nervous System Drugs Sales and Market Share by Application

7 CHINA CENTRAL NERVOUS SYSTEM DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 China Central Nervous System Drugs Sales and Value (2011-2016)
  7.1.1 China Central Nervous System Drugs Sales and Growth Rate (2011-2016)
  7.1.2 China Central Nervous System Drugs Revenue and Growth Rate (2011-2016)
  7.1.3 China Central Nervous System Drugs Sales Price Trend (2011-2016)
7.2 China Central Nervous System Drugs Sales and Market Share by Manufacturers
7.3 China Central Nervous System Drugs Sales and Market Share by Type
7.4 China Central Nervous System Drugs Sales and Market Share by Application

8 EUROPE CENTRAL NERVOUS SYSTEM DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Central Nervous System Drugs Sales and Value (2011-2016)
  8.1.1 Europe Central Nervous System Drugs Sales and Growth Rate (2011-2016)
  8.1.2 Europe Central Nervous System Drugs Revenue and Growth Rate (2011-2016)
  8.1.3 Europe Central Nervous System Drugs Sales Price Trend (2011-2016)
8.2 Europe Central Nervous System Drugs Sales and Market Share by Manufacturers
8.3 Europe Central Nervous System Drugs Sales and Market Share by Type
8.4 Europe Central Nervous System Drugs Sales and Market Share by Application

9 JAPAN CENTRAL NERVOUS SYSTEM DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Central Nervous System Drugs Sales and Value (2011-2016)
  9.1.1 Japan Central Nervous System Drugs Sales and Growth Rate (2011-2016)
  9.1.2 Japan Central Nervous System Drugs Revenue and Growth Rate (2011-2016)
  9.1.3 Japan Central Nervous System Drugs Sales Price Trend (2011-2016)
9.2 Japan Central Nervous System Drugs Sales and Market Share by Manufacturers
9.3 Japan Central Nervous System Drugs Sales and Market Share by Type
9.4 Japan Central Nervous System Drugs Sales and Market Share by Application

10 INDIA CENTRAL NERVOUS SYSTEM DRUGS (VOLUME, VALUE AND SALES PRICE)

10.1 India Central Nervous System Drugs Sales and Value (2011-2016)
  10.1.1 India Central Nervous System Drugs Sales and Growth Rate (2011-2016)
  10.1.2 India Central Nervous System Drugs Revenue and Growth Rate (2011-2016)
  10.1.3 India Central Nervous System Drugs Sales Price Trend (2011-2016)
10.2 India Central Nervous System Drugs Sales and Market Share by Manufacturers
10.3 India Central Nervous System Drugs Sales and Market Share by Type
10.4 India Central Nervous System Drugs Sales and Market Share by Application

11 SOUTHEAST ASIA CENTRAL NERVOUS SYSTEM DRUGS (VOLUME, VALUE AND SALES PRICE)

11.1 Southeast Asia Central Nervous System Drugs Sales and Value (2011-2016)
  11.1.1 Southeast Asia Central Nervous System Drugs Sales and Growth Rate (2011-2016)
  11.1.2 Southeast Asia Central Nervous System Drugs Revenue and Growth Rate (2011-2016)
  11.1.3 Southeast Asia Central Nervous System Drugs Sales Price Trend (2011-2016)
11.2 Southeast Asia Central Nervous System Drugs Sales and Market Share by Manufacturers
11.3 Southeast Asia Central Nervous System Drugs Sales and Market Share by Type
11.4 Southeast Asia Central Nervous System Drugs Sales and Market Share by Application

12 GLOBAL CENTRAL NERVOUS SYSTEM DRUGS MANUFACTURERS ANALYSIS

12.1 Johnson & Johnson
  12.1.1 Company Overview
  12.1.2 Product Information
  12.1.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  12.1.4 Contact Information
12.2 Pfizer
  12.2.1 Company Overview
  12.2.2 Product Information
  12.2.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  12.2.4 Contact Information
12.3 Novartis
  12.3.1 Company Overview
  12.3.2 Product Information
  12.3.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  12.3.4 Contact Information
12.4 Roche
  12.4.1 Company Overview
  12.4.2 Product Information
  12.4.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  12.4.4 Contact Information
12.5 Sanofi-Aventis
  12.5.1 Company Overview
  12.5.2 Product Information
  12.5.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  12.5.4 Contact Information
12.6 Merck
  12.6.1 Company Overview
  12.6.2 Product Information
  12.6.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  12.6.4 Contact Information
12.7 GSK
12.8 Bayer Schering
12.9 Bristol-Myers Squibb
12.10 AbbVie
12.11 Eli Lilly
12.12 AstraZeneca
12.13 Takeda
12.14 Actavis
12.15 Astellas Pharma US
12.16 Teva
12.17 Biogen
12.18 Shire

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 GLOBAL CENTRAL NERVOUS SYSTEM DRUGS MARKET FORECAST (2016-2021)

15.1 Global Central Nervous System Drugs Sales, Revenue Forecast (2016-2021)
15.2 Global Central Nervous System Drugs Sales Forecast by Regions (2016-2021)
15.3 Global Central Nervous System Drugs Sales Forecast by Type (2016-2021)
15.4 Global Central Nervous System Drugs Sales Forecast by Application (2016-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Central Nervous System Drugs
Table Classification of Central Nervous System Drugs
Figure Global Sales Market Share of Central Nervous System Drugs by Type in 2015
Table Applications of Central Nervous System Drugs
Figure Global Sales Market Share of Central Nervous System Drugs by Application in 2015
Figure USA Central Nervous System Drugs Revenue and Growth Rate (2011-2021)
Figure China Central Nervous System Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Central Nervous System Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Central Nervous System Drugs Revenue and Growth Rate (2011-2021)
Figure India Central Nervous System Drugs Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Central Nervous System Drugs Revenue and Growth Rate (2011-2021)
Figure Global Central Nervous System Drugs Sales and Growth Rate (2011-2021)
Figure Global Central Nervous System Drugs Revenue and Growth Rate (2011-2021)
Table Global Central Nervous System Drugs Sales of Key Manufacturers (2011-2016)
Table Global Central Nervous System Drugs Sales Share by Manufacturers (2011-2016)
Figure 2015 Central Nervous System Drugs Sales Share by Manufacturers
Figure 2016 Central Nervous System Drugs Sales Share by Manufacturers
Table Global Central Nervous System Drugs Revenue by Manufacturers (2011-2016)
Table Global Central Nervous System Drugs Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Central Nervous System Drugs Revenue Share by Manufacturers
Table 2016 Global Central Nervous System Drugs Revenue Share by Manufacturers
Table Global Central Nervous System Drugs Sales and Market Share by Type (2011-2016)
Table Global Central Nervous System Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Central Nervous System Drugs by Type (2011-2016)
Figure Global Central Nervous System Drugs Sales Growth Rate by Type (2011-2016)
Table Global Central Nervous System Drugs Revenue and Market Share by Type (2011-2016)
Table Global Central Nervous System Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Central Nervous System Drugs by Type (2011-2016)
Figure Global Central Nervous System Drugs Revenue Growth Rate by Type (2011-2016)
Table Global Central Nervous System Drugs Sales and Market Share by Regions (2011-2016)
Table Global Central Nervous System Drugs Sales Share by Regions (2011-2016)
Figure Sales Market Share of Central Nervous System Drugs by Regions (2011-2016)
Figure Global Central Nervous System Drugs Sales Growth Rate by Regions (2011-2016)
Table Global Central Nervous System Drugs Revenue and Market Share by Regions (2011-2016)
Table Global Central Nervous System Drugs Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Central Nervous System Drugs by Regions (2011-2016)
Figure Global Central Nervous System Drugs Revenue Growth Rate by Regions (2011-2016)
Table Global Central Nervous System Drugs Sales and Market Share by Application (2011-2016)
Table Global Central Nervous System Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Central Nervous System Drugs by Application (2011-2016)
Figure Global Central Nervous System Drugs Sales Growth Rate by Application (2011-2016)
Figure USA Central Nervous System Drugs Sales and Growth Rate (2011-2016)
Figure USA Central Nervous System Drugs Revenue and Growth Rate (2011-2016)
Figure USA Central Nervous System Drugs Sales Price Trend (2011-2016)
Table USA Central Nervous System Drugs Sales by Manufacturers (2011-2016)
Table USA Central Nervous System Drugs Market Share by Manufacturers (2011-2016)
Table USA Central Nervous System Drugs Sales by Type (2011-2016)
Table USA Central Nervous System Drugs Market Share by Type (2011-2016)
Table USA Central Nervous System Drugs Sales by Application (2011-2016)
Table USA Central Nervous System Drugs Market Share by Application (2011-2016)
Figure China Central Nervous System Drugs Sales and Growth Rate (2011-2016)
Figure China Central Nervous System Drugs Revenue and Growth Rate (2011-2016)
Figure China Central Nervous System Drugs Sales Price Trend (2011-2016)
Table China Central Nervous System Drugs Sales by Manufacturers (2011-2016)
Table China Central Nervous System Drugs Market Share by Manufacturers (2011-2016)
Table China Central Nervous System Drugs Sales by Type (2011-2016)
Table China Central Nervous System Drugs Market Share by Type (2011-2016)
Table China Central Nervous System Drugs Sales by Application (2011-2016)
Table China Central Nervous System Drugs Market Share by Application (2011-2016)
Figure Europe Central Nervous System Drugs Sales and Growth Rate (2011-2016)
Figure Europe Central Nervous System Drugs Revenue and Growth Rate (2011-2016)
Figure Europe Central Nervous System Drugs Sales Price Trend (2011-2016)
Table Europe Central Nervous System Drugs Sales by Manufacturers (2011-2016)
Table Europe Central Nervous System Drugs Market Share by Manufacturers (2011-2016)
Table Europe Central Nervous System Drugs Sales by Type (2011-2016)
Table Europe Central Nervous System Drugs Market Share by Type (2011-2016)
Table Europe Central Nervous System Drugs Sales by Application (2011-2016)
Table Europe Central Nervous System Drugs Market Share by Application (2011-2016)
Figure Japan Central Nervous System Drugs Sales and Growth Rate (2011-2016)
Figure Japan Central Nervous System Drugs Revenue and Growth Rate (2011-2016)
Figure Japan Central Nervous System Drugs Sales Price Trend (2011-2016)
Table Japan Central Nervous System Drugs Sales by Manufacturers (2011-2016)
Table Japan Central Nervous System Drugs Market Share by Manufacturers (2011-2016)
Table Japan Central Nervous System Drugs Sales by Type (2011-2016)
Table Japan Central Nervous System Drugs Market Share by Type (2011-2016)
Table Japan Central Nervous System Drugs Sales by Application (2011-2016)
Table Japan Central Nervous System Drugs Market Share by Application (2011-2016)
Figure India Central Nervous System Drugs Sales and Growth Rate (2011-2016)
Figure India Central Nervous System Drugs Revenue and Growth Rate (2011-2016)
Figure India Central Nervous System Drugs Sales Price Trend (2011-2016)
Table India Central Nervous System Drugs Sales by Manufacturers (2011-2016)
Table India Central Nervous System Drugs Market Share by Manufacturers (2011-2016)
Table India Central Nervous System Drugs Sales by Type (2011-2016)
Table India Central Nervous System Drugs Market Share by Type (2011-2016)
Table India Central Nervous System Drugs Sales by Application (2011-2016)
Table India Central Nervous System Drugs Market Share by Application (2011-2016)
Figure Southeast Asia Central Nervous System Drugs Sales and Growth Rate (2011-2016)
Figure Southeast Asia Central Nervous System Drugs Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Central Nervous System Drugs Sales Price Trend (2011-2016)
Table Southeast Asia Central Nervous System Drugs Sales by Manufacturers (2011-2016)
Table Southeast Asia Central Nervous System Drugs Market Share by Manufacturers (2011-2016)
Table Southeast Asia Central Nervous System Drugs Sales by Type (2011-2016)
Table Southeast Asia Central Nervous System Drugs Market Share by Type (2011-2016)
Table Southeast Asia Central Nervous System Drugs Sales by Application (2011-2016)
Table Southeast Asia Central Nervous System Drugs Market Share by Application (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Central Nervous System Drugs Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Central Nervous System Drugs Global Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Central Nervous System Drugs Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Central Nervous System Drugs Global Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Central Nervous System Drugs Global Market Share (2011-2016)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi-Aventis Central Nervous System Drugs Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Central Nervous System Drugs Global Market Share (2011-2016)
Table Bayer Schering Basic Information List
Table Bayer Schering Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Schering Central Nervous System Drugs Global Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Central Nervous System Drugs Global Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AbbVie Central Nervous System Drugs Global Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Central Nervous System Drugs Global Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Central Nervous System Drugs Global Market Share (2011-2016)
Table Takeda Basic Information List
Table Takeda Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Central Nervous System Drugs Global Market Share (2011-2016)
Table Actavis Printing & Packaging Basic Information List
Table Actavis Printing & Packaging Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actavis Printing & Packaging Central Nervous System Drugs Global Market Share (2011-2016)
Table Astellas Pharma US Basic Information List
Table Astellas Pharma US Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Astellas Pharma US Central Nervous System Drugs Global Market Share (2011-2016)
Table Teva Basic Information List
Table Teva Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Central Nervous System Drugs Global Market Share (2011-2016)
Table Biogen Basic Information List
Table Biogen Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen Central Nervous System Drugs Global Market Share (2011-2016)
Table Shire Basic Information List
Table Shire Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Shire Central Nervous System Drugs Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Central Nervous System Drugs
Figure Manufacturing Process Analysis of Central Nervous System Drugs
Figure Central Nervous System Drugs Industrial Chain Analysis
Table Raw Materials Sources of Central Nervous System Drugs Major Manufacturers in 2015
Table Major Buyers of Central Nervous System Drugs
Table Distributors/Traders List
Figure Global Central Nervous System Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Global Central Nervous System Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Central Nervous System Drugs Sales Forecast by Regions (2016-2021)
Table Global Central Nervous System Drugs Sales Forecast by Type (2016-2021)
Table Global Central Nervous System Drugs Sales Forecast by Application (2016-2021)